🟢 Taysha Gene Therapies is trading 5% up today as biotech stocks rise amid sector rotation

Taysha Gene Therapies is trading at $4.30, up 5.13%, alongside biotech-sector strength, with XBI up 2.13% amid rotation into biotech stocks.

• No clear company-specific announcement explaining the November 4 move surfaced in the search; the company’s investor-relations page lists October 1 as its latest release.
• A market listing showed November 4 as an earnings date, but no results were available by 2:10 p.m. ET.